Immune-related RNA signature predicts outcome of PD-1 inhibitor combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma
| Title | Immune-related RNA signature predicts outcome of PD-1 inhibitor combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma |
|---|---|
| Description | RNA-SEQ-DATA |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA011691 |
| Release Date | 2023-09-05 |
| Submitter | Tian-mei Zeng (zengtm@smmu.edu.cn) |
| Organization | Eastern Hepatobiliary Surgery Hospital |
| Submission Date | 2022-09-05 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX001774-01 | RNA-seq data of TFK1 GEM-resis | 1 | Biomarker Data | 53.1 MB | xls | 0 | Controlled |